A collaboration between Vanderbilt University and Washington University researchers produced a population-based cohort study suggesting first-trimester treatment of urinary tract infection (UTI) with trimethoprim-sulfamethoxazole (TMP-SMX) is associated with a higher risk of congenital malformations compared with β-lactam antibiotics, whereas nitrofurantoin and fluoroquinolones show no clear elevated risk.
This article was originally published on MedicalXpress.com